Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance-Reference-Cited by-同舟云学术

Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance

Published:2013-01-18 Issue:3 Volume:88 Page:201-206
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Patnaik Mrinal M.,Lasho Terra L.,Finke Christy M.,Hanson Curtis A.,Hodnefield Janice M.,Knudson Ryan A.,Ketterling Rhett P.,Pardanani Animesh,Tefferi Ayalew

Publisher

Wiley

Subject

Hematology

Reference35 articles.

1. Risk assessment in chronic myelomonocytic leukemia (CMML);Germing;Leuk Lymphoma,2004

2. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications;Asou;Crit Rev Oncol Hematol,2003

3. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate;Ward;Cancer Cell,2010

4. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism;Delgado;Oncogene,2000

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation;Leukemia Research;2024-10

2. Assessing the Methylation Status of Two Potential Key Factors Involved in Cervical Oncogenesis;Reports;2024-08-18

3. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

4. Alternative splicing regulation and its therapeutic potential in bladder cancer;Frontiers in Oncology;2024-07-26

5. Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies;Cancer Cell International;2024-07-21